HU173920B - Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa - Google Patents
Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippaInfo
- Publication number
- HU173920B HU173920B HU75SA2736A HUSA002736A HU173920B HU 173920 B HU173920 B HU 173920B HU 75SA2736 A HU75SA2736 A HU 75SA2736A HU SA002736 A HUSA002736 A HU SA002736A HU 173920 B HU173920 B HU 173920B
- Authority
- HU
- Hungary
- Prior art keywords
- neuraminidase
- hemagglutinin
- mixture
- influenza virus
- selective isolation
- Prior art date
Links
- 101710154606 Hemagglutinin Proteins 0.000 title 1
- 102000005348 Neuraminidase Human genes 0.000 title 1
- 108010006232 Neuraminidase Proteins 0.000 title 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title 1
- 101710176177 Protein A56 Proteins 0.000 title 1
- 239000000185 hemagglutinin Substances 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH44774A CH589453A5 (fr) | 1974-01-14 | 1974-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU173920B true HU173920B (hu) | 1979-09-28 |
Family
ID=4187233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU75SA2736A HU173920B (hu) | 1974-01-14 | 1975-01-13 | Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa |
Country Status (27)
| Country | Link |
|---|---|
| JP (2) | JPS58407B2 (fr) |
| AT (1) | AT345449B (fr) |
| AU (1) | AU500250B2 (fr) |
| BE (1) | BE824372A (fr) |
| CA (1) | CA1049406A (fr) |
| CH (1) | CH589453A5 (fr) |
| CS (1) | CS191254B2 (fr) |
| DD (1) | DD116239A5 (fr) |
| DE (1) | DE2500785B2 (fr) |
| DK (1) | DK140003B (fr) |
| ES (1) | ES433759A1 (fr) |
| FI (1) | FI54053C (fr) |
| FR (1) | FR2257305B1 (fr) |
| GB (1) | GB1498261A (fr) |
| HK (1) | HK56380A (fr) |
| HU (1) | HU173920B (fr) |
| IE (1) | IE40794B1 (fr) |
| IL (1) | IL46426A (fr) |
| MY (1) | MY8100204A (fr) |
| NL (1) | NL166622C (fr) |
| NO (1) | NO143128C (fr) |
| PH (1) | PH14458A (fr) |
| PL (1) | PL93689B1 (fr) |
| SE (1) | SE427238B (fr) |
| SU (1) | SU616997A3 (fr) |
| YU (1) | YU41289B (fr) |
| ZA (1) | ZA75259B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2829089A1 (de) * | 1977-07-13 | 1979-02-01 | Sandoz Ag | Subunit-vakzine |
| JPH0688911B2 (ja) * | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
| TW570803B (en) * | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| EP0919243A1 (fr) | 1997-11-25 | 1999-06-02 | Duphar International Research B.V | Vaccin dont l'adjuvant est constitué de sous-unités B de l'entérotoxine thermolabile (LTB) d'Escherichia coli |
| DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
| CN104474543A (zh) * | 2005-11-01 | 2015-04-01 | 诺华疫苗和诊断有限两合公司 | 经由β-丙内酯处理的残留细胞DNA水平降低的细胞衍生病毒疫苗 |
| RU2496519C2 (ru) * | 2007-08-28 | 2013-10-27 | Бакстер Интернэшнл Инк. | Способ получения препарата, содержащего вирусные антигены, и применение препарата |
| JP6373376B2 (ja) | 2013-11-15 | 2018-08-15 | ノバルティス アーゲー | 残留細胞培養不純物の除去 |
-
1974
- 1974-01-14 CH CH44774A patent/CH589453A5/xx not_active IP Right Cessation
-
1975
- 1975-01-06 FI FI750014A patent/FI54053C/fi not_active IP Right Cessation
- 1975-01-06 DK DK1475AA patent/DK140003B/da not_active IP Right Cessation
- 1975-01-06 NO NO750031A patent/NO143128C/no unknown
- 1975-01-07 SE SE7500130A patent/SE427238B/xx not_active IP Right Cessation
- 1975-01-10 NL NL7500301.A patent/NL166622C/xx not_active IP Right Cessation
- 1975-01-10 DE DE2500785A patent/DE2500785B2/de active Granted
- 1975-01-13 CA CA217,790A patent/CA1049406A/fr not_active Expired
- 1975-01-13 GB GB1290/75A patent/GB1498261A/en not_active Expired
- 1975-01-13 DD DD183614A patent/DD116239A5/xx unknown
- 1975-01-13 HU HU75SA2736A patent/HU173920B/hu not_active IP Right Cessation
- 1975-01-13 IL IL46426A patent/IL46426A/xx unknown
- 1975-01-13 PH PH16702A patent/PH14458A/en unknown
- 1975-01-13 AT AT21475A patent/AT345449B/de not_active IP Right Cessation
- 1975-01-13 ES ES433759A patent/ES433759A1/es not_active Expired
- 1975-01-13 IE IE59/75A patent/IE40794B1/xx unknown
- 1975-01-13 PL PL1975177303A patent/PL93689B1/pl unknown
- 1975-01-13 YU YU58/75A patent/YU41289B/xx unknown
- 1975-01-14 FR FR7501007A patent/FR2257305B1/fr not_active Expired
- 1975-01-14 BE BE152368A patent/BE824372A/fr not_active IP Right Cessation
- 1975-01-14 ZA ZA00750259A patent/ZA75259B/xx unknown
- 1975-01-14 JP JP50006975A patent/JPS58407B2/ja not_active Expired
- 1975-01-14 CS CS75255A patent/CS191254B2/cs unknown
- 1975-01-14 SU SU752101722A patent/SU616997A3/ru active
- 1975-01-14 AU AU77305/75A patent/AU500250B2/en not_active Expired
-
1980
- 1980-10-09 HK HK563/80A patent/HK56380A/xx unknown
-
1981
- 1981-01-29 JP JP56012831A patent/JPS6035326B2/ja not_active Expired
- 1981-12-30 MY MY204/81A patent/MY8100204A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL161462B (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van daarvoor geschikte verbindingen. | |
| HU173920B (hu) | Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa | |
| AU526356B2 (en) | Amino acid intermediates for the preparation of prosta- glandin analogues | |
| BE809668A (nl) | Werkwijze voor de bereiding van een reducerend gas | |
| JPS51133414A (en) | Production of vaccine against viral hepatisis | |
| HU173548B (hu) | Sposob poluchenija rekombinacionnogo shtamma virusa grippa i vakciny soderzhajuhhej ehtot shtamma | |
| IL48062A (en) | Process for the preparation of meta-substituted halogenophenols | |
| CH611518A5 (en) | Process for the preparation of a virus subunit vaccine | |
| CH611338A5 (en) | Process for the preparation of inactivated HB-Ag vaccines | |
| KE3101A (en) | New pharmaceutical compositions and a process for the preparation thereof | |
| ZA753266B (en) | New pharmaceutical compositions and a process for the preparation thereof | |
| CH479700A (de) | Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit | |
| ZA752563B (en) | Process for the preparation of carnitine hydrochloride | |
| PH13148A (en) | A process for the preparation of triazapentadienes | |
| PH12704A (en) | Influenza vaccine containing a recombinant antigenically hybridized virus and method of using the same | |
| PH13837A (en) | Influenza vaccine containing purified neuraminidase antigen and method of using the same | |
| CH609031A5 (en) | A process for the preparation of amines | |
| FI42537C (fi) | Menetelmä uusien antidiabeettisesti vaikuttavien bentsolisulfonyyli-virtsa-aineiden valmistamiseksi | |
| ZM11375A1 (en) | Process for the preparation of poly-(-n-alkyliminoalanes) | |
| CH613445A5 (en) | Process for the preparation of novel N-(p-fluorobenzoylpropyl)-4-piperidylamides | |
| JPS52156920A (en) | Proauction of raw influenza virus vaccine | |
| GB1485916A (en) | Process for the preparation of propargyl amines and products obtained thereby | |
| IL47771A (en) | Process for the polymerization of isoprene | |
| ZA723782B (en) | A process for the preparation of steroids | |
| AU492612B2 (en) | Influenza vaccine containing a recombinant antigenically hybridized virus and method of using thesame |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |